BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8894106)

  • 21. A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.
    Park JD; Lee KJ; Kim DH
    Bioorg Med Chem; 2001 Feb; 9(2):237-43. PubMed ID: 11249116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase A.
    Cross JB; Vreven T; Meroueh SO; Mobashery S; Schlegel HB
    J Phys Chem B; 2005 Mar; 109(10):4761-9. PubMed ID: 16851559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of carboxypeptidase A catalyzed peptide hydrolysis by 3-phenylpropanoate at activating and nonactivating substrate concentrations.
    Poorman R; Kuo M; Johnson DI; Lin S; Sebastian JF
    Can J Biochem; 1979 Apr; 57(4):357-65. PubMed ID: 445224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excess zinc ions are a competitive inhibitor for carboxypeptidase A.
    Hirose J; Ando S; Kidani Y
    Biochemistry; 1987 Oct; 26(20):6561-5. PubMed ID: 3427026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate.
    Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM
    Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of zinc ion on the inhibition of carboxypeptidase A by imidazole-bearing substrate analogues.
    Han MS; Kim DH
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1425-7. PubMed ID: 11378369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of directed mutagenesis to probe the role of tyrosine 198 in the catalytic mechanism of carboxypeptidase A.
    Gardell SJ; Hilvert D; Barnett J; Kaiser ET; Rutter WJ
    J Biol Chem; 1987 Jan; 262(2):576-82. PubMed ID: 3542991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new type of ultrasensitive bioluminogenic enzyme substrates. I. Enzyme substrates with D-luciferin as leaving group.
    Miska W; Geiger R
    Biol Chem Hoppe Seyler; 1988 May; 369(5):407-11. PubMed ID: 3166746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectral titration of active site of carboxypeptidase A.
    Suh J; Hwang BK; Jang I; Oh E
    J Biochem Biophys Methods; 1991; 22(2):167-70. PubMed ID: 2061563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The physical state dependence of carboxypeptidase Aalpha and Agamma kinetics.
    Spilburg CA; Bethune JL; Vallee BL
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3922-6. PubMed ID: 4530272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and crystallization of human carboxypeptidase A.
    Peterson LM; Sokolovsky M; Vallee BL
    Biochemistry; 1976 Jun; 15(12):2501-8. PubMed ID: 938622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General occurrence of binding synergism in zinc proteases and its possible significance.
    Chan WW; Pfuetzner RA
    Eur J Biochem; 1993 Dec; 218(2):529-34. PubMed ID: 8269943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel [125I]iodinated carboxypeptidase A substrate detects a metallopeptidase activity distinct from carboxypeptidase A in brain.
    Normant E; Schwartz JC; Gros C
    Neuropeptides; 1996 Feb; 30(1):13-7. PubMed ID: 8868294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of new immobilized-stabilized carboxypeptidase a derivative for production of aromatic free hydrolysates of proteins.
    Tardioli PW; Fernández-Lafuente R; Guisán JM; Giordano RL
    Biotechnol Prog; 2003; 19(2):565-74. PubMed ID: 12675602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and characterization of human pancreatic preprocarboxypeptidase A1 and preprocarboxypeptidase A2.
    Laethem RM; Blumenkopf TA; Cory M; Elwell L; Moxham CP; Ray PH; Walton LM; Smith GK
    Arch Biochem Biophys; 1996 Aug; 332(1):8-18. PubMed ID: 8806703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enzyme intermediates with the C-terminal products of substrate hydrolysis by carboxypeptidase A and chymotrypsin. Use of the free energy linearity principle].
    Kozlov LV
    Biokhimiia; 1980 Aug; 45(8):1442-7. PubMed ID: 7236796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of action of carboxypeptidase A in ester hydrolysis.
    Makinen MW; Yammura K; Kaiser ET
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):3882-6. PubMed ID: 1069272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex between carboxypeptidase A and a hydrated ketomethylene substrate analogue.
    Shoham G; Christianson DW; Oren DA
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):684-8. PubMed ID: 3422451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of carboxypeptidase-Y-catalysed peptide semisynthesis.
    Christensen U; Drøhse HB; Mølgaard L
    Eur J Biochem; 1992 Dec; 210(2):467-73. PubMed ID: 1459131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Theoretical conformational analysis of a substrate component of tetrahedral intermediates and of acyl-enzyme of carboxypeptidase A].
    Paslen VV; Lipkind GM
    Mol Biol (Mosk); 1981; 15(2):408-23. PubMed ID: 7242537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.